Akari Therapeutics PLC (AKTX)
2.429
-0.35
(-12.61%)
USD |
NASDAQ |
Nov 04, 16:00
2.42
-0.01
(-0.39%)
After-Hours: 20:00
Akari Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2024 | 4.437 |
| March 27, 2024 | 4.425 |
| March 26, 2024 | 4.484 |
| March 25, 2024 | 4.520 |
| March 22, 2024 | 4.306 |
| March 21, 2024 | 4.354 |
| March 20, 2024 | 4.520 |
| March 19, 2024 | 4.615 |
| March 18, 2024 | 4.758 |
| March 15, 2024 | 4.687 |
| March 14, 2024 | 4.853 |
| March 13, 2024 | 5.115 |
| March 12, 2024 | 5.091 |
| March 11, 2024 | 5.115 |
| March 08, 2024 | 5.091 |
| March 07, 2024 | 5.282 |
| March 06, 2024 | 5.234 |
| March 05, 2024 | 5.377 |
| March 04, 2024 | 5.353 |
| March 01, 2024 | 5.424 |
| February 29, 2024 | 5.591 |
| February 28, 2024 | 5.282 |
| February 27, 2024 | 5.448 |
| February 26, 2024 | 5.642 |
| February 23, 2024 | 5.567 |
| Date | Value |
|---|---|
| February 22, 2024 | 5.329 |
| February 21, 2024 | 5.519 |
| February 20, 2024 | 5.686 |
| February 16, 2024 | 5.329 |
| February 15, 2024 | 5.662 |
| February 14, 2024 | 5.710 |
| February 13, 2024 | 5.710 |
| February 12, 2024 | 5.710 |
| February 09, 2024 | 5.710 |
| February 08, 2024 | 5.829 |
| February 07, 2024 | 6.114 |
| February 06, 2024 | 6.269 |
| February 05, 2024 | 5.971 |
| February 02, 2024 | 5.924 |
| February 01, 2024 | 6.216 |
| January 31, 2024 | 6.233 |
| January 30, 2024 | 6.209 |
| January 29, 2024 | 6.423 |
| January 26, 2024 | 6.304 |
| January 25, 2024 | 6.181 |
| January 24, 2024 | 6.328 |
| January 23, 2024 | 6.328 |
| January 22, 2024 | 5.948 |
| January 19, 2024 | 6.186 |
| January 18, 2024 | 7.161 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.341
Minimum
Mar 30 2023
7221.70
Maximum
Mar 03 2020
334.28
Average
9.20
Median
Price to Book Value Benchmarks
| DBV Technologies SA | 0.9524 |
| Cellectis SA | 1.192 |
| Adaptimmune Therapeutics PLC | 2.190 |
| Biodexa Pharmaceuticals PLC | 0.2989 |
| NuCana PLC | 0.7432 |
Price to Book Value Related Metrics
| Price | 2.429 |
| Earnings Yield | -89.11% |
| Market Cap | 28.93M |